Related Experiment Video
Updated: Aug 6, 2026
05:59
High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Zolpidem vs. Emerging Hypnotics: Neuropsychiatric Effects and Ethical Considerations
Tawqeer Shafi1, Zora Singh2, Puja Gulati1
1School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.
CNS & Neurological Disorders Drug Targets
|July 20, 2026
Summary
Zolpidem, a common insomnia treatment, is linked to serious neuropsychiatric side effects like hallucinations and sleep-driving. Newer hypnotics, such as orexin receptor antagonists, show better safety profiles with comparable efficacy.
Area of Science:
- Pharmacology
- Neuroscience
- Sleep Medicine
Background:
- Zolpidem is a widely prescribed non-benzodiazepine hypnotic for insomnia.
- Despite perceived safety, it is associated with significant neuropsychiatric adverse effects, including hallucinations and complex sleep behaviors.
- Limited comparative data exist between zolpidem and newer hypnotic agents.
Purpose of the Study:
- To review and compare the safety and efficacy of zolpidem against newer insomnia treatments.
- To highlight the neuropsychiatric risks associated with zolpidem use.
Main Methods:
- A narrative literature review was performed.
- Databases searched included PubMed/MEDLINE, Scopus, and Web of Science.
- Studies published between 2020 and 2025 were included.
Main Results:
- Zolpidem use is frequently associated with complex sleep behaviors, amnesia, and hallucinations, particularly at higher doses or with psychiatric comorbidities.
- Orexin receptor antagonists demonstrate fewer adverse effects compared to zolpidem.
- Melatonin-based therapies offer a good safety profile but may have reduced hypnotic efficacy.
Conclusions:
- Zolpidem, while effective for insomnia, carries a notable risk of neuropsychiatric adverse effects, especially in vulnerable populations (elderly, psychiatric patients, women, those on polypharmacy).
- Individualized risk-benefit assessments are crucial before prescribing zolpidem, considering patient-specific factors.
- Emerging hypnotics may offer improved safety profiles for insomnia management.
Related Concept Videos
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...